Codes / ICD10CM / M1A.1721

M1A.1721 Lead-induced chronic gout, left ankle and foot, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Left Ankle and Foot, with Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the left ankle and foot, with the presence of tophi (urate crystal deposits), resulting in persistent symptoms and potential tissue damage if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the left ankle or foot
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited mobility in the left ankle or foot
  • Visible or palpable tophi (urate crystal deposits) in the left ankle or foot
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms tophi. Clinical history of lead exposure is also considered.

Treatment Options

Treatment focuses on reducing uric acid levels, managing symptoms, and addressing lead exposure. Medications may include urate-lowering agents, anti-inflammatories, or colchicine. Tophi may require surgical removal in severe cases. Reducing lead exposure is critical to prevent progression.

Prognosis and Follow-Up

Prognosis depends on early intervention and lead exposure control. Untreated cases may lead to joint deformity or chronic pain. Regular follow-up with uric acid monitoring and imaging is recommended to assess treatment response and prevent complications.

Complications

  • Chronic joint damage or deformity in the left ankle or foot
  • Persistent pain and reduced mobility
  • Increased risk of kidney stones or renal impairment
  • Worsening tophi formation

Lifestyle & Prevention

  • Avoid or minimize lead exposure (e.g., occupational safety measures)
  • Maintain a low-purine diet to reduce uric acid production
  • Stay hydrated to support uric acid excretion
  • Follow prescribed medications consistently

When to Seek Professional Help

Seek care if experiencing severe joint pain, swelling, or redness in the left ankle or foot, or if tophi are visible or growing. Prompt evaluation is needed to prevent permanent joint damage.

Tips for Medical Coders

Use this code for lead-induced chronic gout affecting the left ankle and foot with documented tophi. Ensure clinical documentation specifies the left-sided involvement and presence of tophi. Verify lead exposure history and gout-related symptoms to support code assignment.

Book a walkthrough

M1A.1721 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.